/
Other
Absorption
7
Pipeline Programs↗
3
Active Trials↗
84
Companies Involved↗
Absorption is an early-stage landscape with 7 programs across 84 companies. The most active players are Nacuity Pharmaceuticals, Inc., Chiesi SA/NV.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 1
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
286
clinical trials
Completed255 · 89%
Terminated11 · 4%
Unknown status10 · 3%
Withdrawn5 · 2%
Suspended2 · 1%
Not yet recruiting2 · 1%
Other1 · 0%
Clinical Trials
Trial Activity
286 trials
Page 1 of 20
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)